Purpose: Raman spectroscopy can quickly and accurately diagnose tissue in near real-time. This study evaluated the capacity of Raman spectroscopy to diagnose pediatric brain tumors. Experimental Design: Samples of untreated pediatric medulloblastoma (4 samples and 4 patients), glioma (i.e. astrocytoma, oligodendroglioma, ependymoma, ganglioglioma and other gliomas; 27 samples and 19 patients), and normal brain samples (33 samples and 5 patients) were collected fresh from the operating room or from our frozen tumor bank. Samples were divided and tested using routine pathology and Raman spectroscopy. Twelve Raman spectra were collected per sample. Support vector machine analysis was used to classify spectra using the pathology diagnosis as the gold standard. Results: Normal brain (321 spectra), glioma (246 spectra) and medulloblastoma (82 spectra) were identified with 96.9, 96.7 and 93.9% accuracy, respectively, when compared with each other. High-grade ependymomas (41 spectra) were differentiated from low-grade ependymomas (25 spectra) with 100% sensitivity and 96.0% specificity. Normal brain tissue was distinguished from low-grade glioma (118 spectra) with 91.5% sensitivity and 97.8% specificity. For these analyses, the tissue-level classification was determined to be 100% accurate. Conclusion: These results suggest Raman spectroscopy can accurately distinguish pediatric brain neoplasms from normal brain tissue, similar tumor types from each other and high-grade from low-grade tumors.

Keywords:
Raman spectroscopy, Brain neoplasm, Diagnostics
1.
Krafft C, Sergo V: Biomedical applications of Raman and infrared spectroscopy to diagnose tissues. Spectroscopy 2006;20:195–218.
2.
Haka AS, et al: Diagnosing breast cancer by using Raman spectroscopy. Proc Natl Acad Sci USA 2005;102:12371–12376.
3.
Kast RE, et al: Raman spectroscopy can differentiate malignant tumors from normal breast tissue and detect early neoplastic changes in a mouse model. Biopolymers 2008;89:235–241.
4.
Wills H, et al: Raman spectroscopy detects and distinguishes neuroblastoma and related tissues in fresh and (banked) frozen specimens. J Pediatr Surg 2009;44:386–391.
5.
Wills H, et al: Diagnosis of Wilms’ tumor using near-infrared Raman spectroscopy. J Pediatr Surg 2009;44:1152–1158.
6.
Krafft C, et al: Disease recognition by infrared and Raman spectroscopy. J Biophotonics 2009;2:13–28.
7.
Kanter E, et al: Application of Raman spectroscopy for cervical dysplasia diagnosis. J Biophotonics 2009;2:81–90.
8.
Nijssen A, et al: Discriminating basal cell carcinoma from perilesional skin using high wave-number Raman spectroscopy. J Biomed Optics 2007;12:034004.
9.
Shetty G, et al: Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. Br J Cancer 2006;94:1460–1464.
10.
Lakshmi RJ, et al: Tissue Raman spectroscopy for the study of radiation damage: brain irradiation of mice. Radiat Res 2002;157:175–182.
11.
Krafft C, et al: Near infrared Raman spectra of human brain lipids. Spectrochim Acta A Mol Biomol Spectrosc 2005;61:1529–1535.
12.
Wolthuis R, et al: Determination of water concentration in brain tissue by Raman spectroscopy. Anal Chem 2001;73:3915–3920.
13.
Koljenovic S, et al: Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by Raman spectroscopy. Lab Invest 2002;82:1265–1277.
14.
Krafft C, et al: Methodology for fiber-optic Raman mapping and FTIR imaging of metastases in mouse brains. Anal Bioanal Chem 2007;389:1122–1142.
15.
Krafft C, et al: Near-infrared Raman spectroscopy to study the composition of human brain tissue and tumors. Proceedings of SPIE/The International Society for Optical Engineering. Diagn Opt Spectroscopy Biomed 2003;5141:230–236.
16.
Krafft C, et al: Near infrared Raman spectroscopic mapping of native brain tissue and intracranial tumors. Analyst 2005;130:1070–1077.
17.
Aydin O, et al: Differentiation of healthy brain tissue and tumors using surface-enhanced Raman scattering. Appl Spectroscopy 2009;63:1095–1100.
18.
Kirsch M, et al: Raman spectroscopic imaging for in vivo detection of cerebral brain metastases. Anal Bioanal Chem 2010;398:1707–1713.
19.
Koljenovic S, et al: Detection of meningioma in dura mater by Raman spectroscopy. Anal Chem 2005;77:7958–7965.
20.
Beljebbar A, et al: Ex vivo and in vivo diagnosis of C6 glioblastoma development by Raman spectroscopy coupled to a microprobe. Anal Bioanal Chem 2010;398:477–487.
21.
Koehler M, et al: Characterization of lipid extracts from brain tissue and tumors using Raman spectroscopy and mass spectrometry. Anal Bioanal Chem 2009;393:1513–1520.
22.
Reisner LA, Cao A, Pandya AK: An integrated software system for processing, analyzing, and classifying Raman spectra. Chemometr Intell Lab Syst 2011;105:83–90.
23.
Cortes C, Vapnik V: Support-vector networks. Mach Learn 1995;20:273–297.
24.
Zomer S, et al: Support vector machines for the discrimination of analytical chemical data: application to the determination of tablet production by pyrolysis-gas chromatography-mass spectrometry. Analyst 2004;129:175–181.
25.
Majumder SK, Ghosh N, Gupta PK: Support vector machine for optical diagnosis of cancer. J Biomed Opt 2005;10:024034.
26.
Widjaja E, Zheng W, Huang Z: Classification of colonic tissues using near-infrared Raman spectroscopy and support vector machines. Int J Oncol 2008;32:653–662.
27.
Sattlecker M, et al: Investigation of support vector machines and Raman spectroscopy for lymph node diagnostics. Analyst 2010;135:895–901.
28.
Lin W-C, et al: Brain tumor demarcation using in vitro spectroscopy; an in vitro study. J Biomed Opt 2000;5:214–220.
29.
Cao A, et al: A robust method for automated background subtraction of tissue fluorescence. J Raman Spectroscopy 2007;38:1199–1205.
30.
Chih-Wei H, Chih-Jen L: A comparison of methods for multiclass support vector machines. IEEE Trans Neur Netw 2002;13:415–425.
31.
Haka AS, et al: In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy. Cancer Res 2006;66:3317–3322.
32.
Hales R, et al: Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neuro-Oncol 2010;99:65–71.
33.
Kan P, et al: Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. J Neurosurg 2004;100:700–705.
34.
Merchant TE, Pollack IF, Loeffler JS: Brain tumors across the age spectrum: biology, therapy, and late effects. Semin Radiat Oncol 2010;20:58–66.
35.
Bristol RE: Low-grade glial tumors: are they all the same? Semin Pediatr Neurol 2009;16:23–26.
36.
Hyder D, et al: Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience. J Neuro-Oncol 2007;83:1–8.
37.
Sepulveda Sanchez J, et al: Classification of oligodendroglial tumors based on histopathology criteria is a significant predictor of survival – clinical, radiological and pathologic long-term follow-up analysis. Clin Neuropathol 2009;28:11–20.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.